NASDAQ
ImmunityBio, Inc. (IBRX) has a revenue compound annual growth rate of 184.76% over 5 years and 85.41% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.